Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis.
about
Protease inhibition as new therapeutic strategy for GI diseasesAntimicrobial proteins in intestine and inflammatory bowel diseasesFecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and ObesityCurrent Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine ModelsProtectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection.Raised trappin2/elafin protein in cervico-vaginal fluid is a potential predictor of cervical shortening and spontaneous preterm birth.Trappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:CNovel role of the serine protease inhibitor elafin in gluten-related disorders.Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies.Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2)Pea (Pisum sativum L.) seed albumin extracts show anti-inflammatory effect in the DSS model of mouse colitis.Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute RejectionElafin, an inhibitor of elastase, is a prognostic indicator in breast cancerWAP domain proteins as modulators of mucosal immunity.Antimicrobial peptides and colitis.New therapeutic avenues in ulcerative colitis: thinking out of the box.Inflammatory signals that regulate intestinal epithelial renewal, differentiation, migration and cell death: Implications for necrotizing enterocolitis.Transglutaminase as a therapeutic target for celiac disease.Pathophysiological roles of proteases in gastrointestinal disease.Human airway trypsin-like protease, a serine protease involved in respiratory diseases.Regulation of intestinal permeability: The role of proteasesProtease-Activated Receptor 2 contributes to Toxoplasma gondii-mediated gut inflammation.Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci.Protease-activated receptors as therapeutic targets in visceral pain.Intracolonically administered adeno-associated virus-bone morphogenetic protein-7 ameliorates dextran sulphate sodium-induced acute colitis in rats.Host Defense Peptide Expression in Human Cervical Cells and Regulation by 1,25-Dihydroxyvitamin D3 in the Presence of Cytokines and Bacterial Endotoxin.Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine.Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease.Thrombin modifies growth, proliferation and apoptosis of human colon organoids: a protease-activated receptor 1- and protease-activated receptor 4-dependent mechanism
P2860
Q26747722-90899DA8-2A05-440B-BB21-7DA38FC92DE9Q27023239-7B8BD42C-CCA1-4B06-BD4C-EF1CEAC850C6Q28070349-49997449-4D35-49FA-989D-4DC33C27EE6FQ28083627-9AFDDF82-EF96-4B24-815B-AB86E98349D5Q33569384-795102E5-40EB-4CA9-97AD-F46C715B4D9FQ33974985-C8E3AD1F-6961-4A7E-9151-C6CFC75B0749Q34251265-73189332-C555-4ED1-B572-87F1E8A106F3Q34449346-C90D8AD4-2E99-45B9-AA70-B0796EF3874DQ34786166-0BFBBCAB-0269-496E-A956-E6E6FAA5E399Q35079179-861BF48C-9635-4FF6-8743-C8F54AEA8152Q35107372-AD526AAE-50F0-419B-A74C-0DB60C09FFB7Q35550110-2DE2F955-644F-42D7-B8F3-FD17F0869FFCQ35761558-0197C37B-1A10-4E34-ACD8-1396A47DA7E1Q36903296-8E383F38-191E-4841-8B83-A4537E862F1AQ37936531-A1EE0A58-6E8E-4E7A-A424-CE781555D570Q38040831-8A698B59-2827-4175-BC04-0B940C2DA437Q38150670-1E2E2998-914F-486D-93AE-0A96013B488DQ38188656-B038BEBD-940D-4041-8D07-A68285694BB3Q38269678-E478B3D2-7956-4642-AEDB-B93E3503446AQ38678675-D4E7B4FF-D54F-4194-95DB-D8339D67F07CQ39149977-EB53A3FE-03AD-451C-884D-4A6ED52C266AQ39239228-7A29357D-C2D4-46D5-B2F2-FE0E2477E097Q40062647-282548DB-D4F3-4C67-90FE-72F7E0C302B6Q41981077-6FF0271F-CC45-48B2-883F-1DF774D2542CQ42849011-A7CB3465-8E8F-4C3F-A3F2-87DF0B8BCB4EQ44073977-19EF7D1D-FD71-4B6A-9B8B-7CC34BB23105Q47438618-A231749B-46DC-491F-93DC-5A147FCB2158Q47588260-AE686891-B6B6-4970-9ABB-E3C5046BC454Q50320364-D146D327-F6BA-403E-9139-F57712D59F7DQ55268565-F1D00B67-B828-4CA3-A5E3-F6EE277BBBD4Q58796994-5C7117F3-4C1F-4E42-8AE6-D2B01E1C03A9
P2860
Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Modifying the protease, antipr ...... on protects mice from colitis.
@en
Modifying the protease, antipr ...... on protects mice from colitis.
@nl
type
label
Modifying the protease, antipr ...... on protects mice from colitis.
@en
Modifying the protease, antipr ...... on protects mice from colitis.
@nl
prefLabel
Modifying the protease, antipr ...... on protects mice from colitis.
@en
Modifying the protease, antipr ...... on protects mice from colitis.
@nl
P2093
P50
P1433
P1476
Modifying the protease, antipr ...... on protects mice from colitis.
@en
P2093
Azzaq Belaaouaj
Camila Squarzoni-Dale
Corinne Rolland
Delphyne Descamps
Dieter Jenne
Emmanuel Mas
Jean-Pierre Vinel
Julien Wartelle
Laurence Martin
Laurent Alric
P304
P356
10.1053/J.GASTRO.2010.12.050
P407
P577
2011-01-01T00:00:00Z